CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma

被引：0
|
作者：
YueGuo Li
Hai Peng Yu
Peng Zhang
机构：
[1] Tianjin Medical University Cancer Institute and Hospital,Department of Clinical Laboratory
[2] National Clinical Research Center for Cancer,Department of Interventional Therapy
[3] Key Laboratory of Cancer Prevention and Therapy,undefined
[4] The National “863” Program of Clinical Research Laboratory,undefined
[5] Tianjin Medical University Cancer Institute and Hospital,undefined
[6] National Clinical Research Center for Cancer,undefined
[7] Key Laboratory of Cancer Prevention and Therapy,undefined
[8] The National “863” Program of Clinical Research Laboratory,undefined
来源：
Hepatology International | 2016年 / 10卷
关键词：
Hepatocellular carcinoma; CCL15; Immunohistochemistry; Survival time;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：488 / 492
页数：4
相关论文
共 50 条
  • [1] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    Li, YueGuo
    Yu, Hai Peng
    Zhang, Peng
    [J]. HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 488 - 492
  • [2] Identification of serum CCL15 in hepatocellular carcinoma
    Y Li
    J Wu
    W Zhang
    N Zhang
    H Guo
    [J]. British Journal of Cancer, 2013, 108 : 99 - 106
  • [3] Identification of serum CCL15 in hepatocellular carcinoma
    Li, Y.
    Wu, J.
    Zhang, W.
    Zhang, N.
    Guo, H.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (01) : 99 - 106
  • [4] Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
    Zhu, Zebin
    Zhang, Yixi
    Huang, Chensong
    Tang, Yunhua
    Sun, Chengjun
    Ju, Weiqiang
    He, Xiaoshun
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5559 - 5572
  • [5] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [6] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    [J]. Medical Oncology, 2013, 30
  • [7] Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Jiang, Jie
    Liu, Bin
    Liu, Ruilin
    Yang, Wenzhuo
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2517 - 2537
  • [8] Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma
    Kong, Jienan
    Zhou, Xianchun
    Liu, Shusen
    Jin, Tiefeng
    Piao, Yingshi
    Liu, Chao
    Lin, Zhenhua
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (06): : 3018 - 3027
  • [9] FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
    Wang, Yan
    Sun, Mengjing
    Liu, Jibin
    Liu, Ying
    Jiang, Chunyi
    Zhu, Huijun
    Wang, Wei
    Wang, Yao
    [J]. ONCOLOGY LETTERS, 2020, 19 (01) : 795 - 804
  • [10] Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Han, C-P
    Yu, Y-H
    Wang, A-G
    Tian, Y.
    Zhang, H-T
    Zheng, Z-M
    Liu, Y-S
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (17) : 5481 - 5489
12345